3D printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals
3D printing technologies enable medicine customization adapted to patients' needs. There
are several 3D printing techniques available, but majority of dosage forms and medical …
are several 3D printing techniques available, but majority of dosage forms and medical …
Nanotechnology-based drug delivery systems for control of microbial biofilms: a review
MA Dos Santos Ramos, PB Da Silva… - International journal …, 2018 - Taylor & Francis
Since the dawn of civilization, it has been understood that pathogenic microorganisms
cause infectious conditions in humans, which at times, may prove fatal. Among the different …
cause infectious conditions in humans, which at times, may prove fatal. Among the different …
[HTML][HTML] Cyclodextrin-based dermatological formulations: Dermopharmaceutical and cosmetic applications
L Ferreira, F Mascarenhas-Melo, S Rabaça… - Colloids and Surfaces B …, 2023 - Elsevier
The progress in new delivery systems for active ingredients has boosted the
dermopharmaceutical and cosmetic fields by allowing formulations to display enhanced skin …
dermopharmaceutical and cosmetic fields by allowing formulations to display enhanced skin …
Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery
The development of dissolving microneedles (DMN) is one of the advanced technologies in
transdermal drug delivery systems, which precisely deliver the drugs through a rapid …
transdermal drug delivery systems, which precisely deliver the drugs through a rapid …
Liposomal amphotericin B for treatment of leishmaniasis: from the identification of critical physicochemical attributes to the design of effective topical and oral …
F Frézard, MMG Aguiar, LAM Ferreira, GS Ramos… - Pharmaceutics, 2022 - mdpi.com
The liposomal amphotericin B (AmB) formulation, AmBisome®, still represents the best
therapeutic option for cutaneous and visceral leishmaniasis. However, its clinical efficacy …
therapeutic option for cutaneous and visceral leishmaniasis. However, its clinical efficacy …
Physicochemical properties and fungicidal activity of inclusion complexes of fungicide chlorothalonil with β-cyclodextrin and hydroxypropyl-β-cyclodextrin
S Gao, Y Liu, J Jiang, Q Ji, Y Fu, L Zhao, C Li… - Journal of Molecular …, 2019 - Elsevier
Chlorothalonil (CHT) suffered from its poor water solubility, which limited the application of
CHT and might cause environmental pollution due to the use of organic solvents. In our …
CHT and might cause environmental pollution due to the use of organic solvents. In our …
Self-assembling, supramolecular chemistry and pharmacology of amphotericin B: Poly-aggregates, oligomers and monomers
R Fernández-García, JC Muñoz-García… - Journal of Controlled …, 2022 - Elsevier
Antifungal drugs such as amphotericin B (AmB) interact with lipids and phospholipids
located on fungal cell membranes to disrupt them and create pores, leading to cell apoptosis …
located on fungal cell membranes to disrupt them and create pores, leading to cell apoptosis …
Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases
JS Lanza, S Pomel, PM Loiseau… - Expert opinion on drug …, 2019 - Taylor & Francis
Introduction: Among the drugs in clinical use for the treatment of leishmaniases,
amphotericin B (AmB) is the most effective and has been the most extensively studied for the …
amphotericin B (AmB) is the most effective and has been the most extensively studied for the …
[HTML][HTML] Out of control: the need for standardised solvent approaches and data reporting in antibiofilm assays incorporating dimethyl-sulfoxide (DMSO)
K Summer, J Browne, M Hollanders, K Benkendorff - Biofilm, 2022 - Elsevier
Bacteria in biofilm formations are up to 1000 times less susceptible to antibiotics than their
planktonic counterparts. Recognition of the role of biofilms in∼ 80% of chronic infections …
planktonic counterparts. Recognition of the role of biofilms in∼ 80% of chronic infections …
Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis
L Sosa, B Clares, HL Alvarado, N Bozal… - … , Biology and Medicine, 2017 - Elsevier
The present study was designed to develop a nanoemulsion formulation of Amphotericin B
(AmB) for the treatment of skin candidiasis and aspergillosis. Several ingredients were …
(AmB) for the treatment of skin candidiasis and aspergillosis. Several ingredients were …